Omeros (OMER) Cash & Equivalents (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -80.27% |
| Dec 31, 2025 | 303.34% |
| Sep 30, 2025 | -91.66% |
| Jun 30, 2025 | 573.55% |
| Mar 31, 2025 | 25.32% |
| Dec 31, 2024 | -97.24% |
| Sep 30, 2024 | -22.47% |
| Jun 30, 2024 | -31.00% |
| Mar 31, 2024 | 3,141.38% |
| Dec 31, 2023 | -76.81% |
| Sep 30, 2023 | 364.24% |
| Jun 30, 2023 | 73.68% |
| Mar 31, 2023 | -65.48% |
| Dec 31, 2022 | -95.02% |
| Sep 30, 2022 | 1,467.38% |
| Jun 30, 2022 | -90.08% |
| Mar 31, 2022 | 41.06% |
| Dec 31, 2021 | 1,259.51% |
| Sep 30, 2021 | -41.62% |
| Jun 30, 2021 | 41.13% |
| Mar 31, 2021 | -14.29% |
| Dec 31, 2020 | -50.18% |
| Sep 30, 2020 | 953.75% |
| Jun 30, 2020 | -71.83% |
| Mar 31, 2020 | 129.03% |
| Dec 31, 2019 | -65.17% |
| Sep 30, 2019 | 122.50% |
| Jun 30, 2019 | -1.33% |
| Mar 31, 2019 | -31.29% |
| Dec 31, 2018 | 111.70% |
| Sep 30, 2018 | -3.33% |
| Jun 30, 2018 | 142.47% |
| Mar 31, 2018 | -64.97% |
| Dec 31, 2017 | 230.80% |
| Sep 30, 2017 | -69.70% |
| Jun 30, 2017 | 164.12% |
| Mar 31, 2017 | -42.36% |
| Dec 31, 2016 | -78.40% |
| Sep 30, 2016 | 124.38% |
| Jun 30, 2016 | 369.22% |
| Mar 31, 2016 | -28.35% |
| Dec 31, 2015 | 127.12% |
| Sep 30, 2015 | -76.53% |
| Jun 30, 2015 | 77.72% |
| Mar 31, 2015 | 307.06% |
| Dec 31, 2014 | -52.80% |
| Sep 30, 2014 | -51.08% |
| Jun 30, 2014 | 170.37% |
| Mar 31, 2014 | -59.03% |
| Dec 31, 2013 | 20.35% |
| Sep 30, 2013 | -32.98% |
| Jun 30, 2013 | 0.00% |
| Mar 31, 2013 | 12.89% |
| Dec 31, 2012 | 43.40% |
| Sep 30, 2012 | -85.42% |
| Jun 30, 2012 | -56.74% |
| Mar 31, 2012 | 319.53% |
| Dec 31, 2011 | -18.06% |
| Sep 30, 2011 | 17.53% |
| Jun 30, 2011 | 6.07% |
| Mar 31, 2011 | 19.62% |
| Dec 31, 2010 | 17.24% |
| Sep 30, 2010 | -2.68% |